Monday's Health Winners & Losers

BioCryst Pharmaceuticals is rising.
Author:
Publish date:

BioCryst Pharmaceuticals

(BCRX) - Get Report

was rising after the H5N1 strain of the bird flu disease was confirmed in the U.K., leading to the destruction of 159,000 turkeys in the country. BioCryst, which manufactures vaccines for the bird flu, was rising 64 cents, or 6.3%, to $10.75.

Amylin Pharmaceuticals

(AMLN)

was higher by $1.07, or 2.8%, to $39.64 after Leerink Swann upgraded the stock to outperform from market perform.

Shares of

Columbia Laboratories

(CBRX)

plummeted 67.3% after the company said a clinical trial of a drug failed to prevent preterm births in a late-stage study. Columbia Laboratories was losing $3.10 to $1.51.

Shares of

Vertex Pharmaceuticals

(VRTX) - Get Report

slumped another 3%, extending Friday's 3% loss. On Thursday, the company said it expects losses to widen in 2007 as it invests more in its hepatitis C drug. Vertex was losing $1 to $32.73.

Among health care stocks gaining ground,

Tercica

(TRCA)

was rising 6.6% to $5.96,

Xoma

(XOMA) - Get Report

was gaining 5.2% at $2.82, and

Millennium Pharmaceuticals

(MLNM)

was higher by 1% to $11.25.

As for decliners,

Illumina

(ILMN) - Get Report

was sinking 3.9% to $35.71,

Elan

(ELN)

was shedding 1.2% to $13.32,

Biogen Idec

(BIIB) - Get Report

was off 0.8% at $48.91, and

Celgene

(CELG) - Get Report

was losing 0.8% to $54.99.